Novartis Pharma AG

Bayesian Logistic Regression for Oncology Dose-Escalation Trials

Novartis Pharma AG , Sebastian Weber , Lukas A. Widmer , Andrew Bean , Trustees of Columbia University

R Bayesian Evidence Synthesis Tools

Novartis Pharma AG , Sebastian Weber , Beat Neuenschwander , Heinz Schmidli , Baldur Magnusson , Yue Li , Satrajit Roychoudhury , Trustees of Columbia University

'ggplot2' Based Tool to Facilitate Diagnostic Plots for NLME Models

Amine Gassem , Bruno Bieth , Irina Baltcheva , Thomas Dumortier , Christian Bartels , Souvik Bhattacharya , Inga Ludwig , Ines Paule , Didier Renard , Matthew Fidler , Seid Hamzic , Benjamin Guiastrennec , Kyle T Baron , Qing Xi Ooi , Novartis Pharma AG

Monitoring Overall Survival in Pivotal Trials in Indolent Cancers

Thomas Fleming , Lisa Hampson , Bharani Bharani-Dharan , Frank Bretz , Arunava Chakravartty , Thibaud Coroller , Evanthia Koukouli , Janet Wittes , Nigel Yateman , Emmanuel Zuber , Novartis Pharma AG

Exploratory Graphics for Pharmacometrics

Andrew Stein , Alison Margolskee , Fariba Khanshan , Konstantin Krismer , Matthew Fidler , Novartis Pharma AG